Author Interviews, JAMA, Karolinski Institute, Pharmacology, Schizophrenia / 24.02.2019
Not All Polypharmacy for Schizophrenia is Bad
MedicalResearch.com Interview with:
Jari Tiihonen, MD, PhD
Professor, Department of Clinical Neuroscience
Karolinska Institutet
Stockholm, Sweden
MedicalResearch.com: What is the background for this study?
Response: The effectiveness of antipsychotic combination therapy in schizophrenia relapse prevention is controversial, and use of multiple agents is generally believed to impair physical well-being. But the evidence for this are weak and antipsychotic polypharmacy is widely used.
(more…)